Skip to content
Scientific Publications

NX210c Demonstrates Therapeutic Potential to Restore Blood–Brain Barrier in a QSP Model of Relapsing–Remitting Multiple Sclerosis

International Journal of Molecular Sciences

Giulia Russo 1,2, Fianne Sips 3, Simona Catozzi 4, Pauline Bambury 4, Annette Janus 5, Mario Torchia 4, Valentina Di Salvatore 1 , Luca Emili 4, Daniel Röshammar 4,*, Francesco Pappalardo 1,2 and Yann Godfrin 5

      1. Department of Drug and Health Sciences, Università degli Studi di Catania, 95125 Catania, Italy; giulia.russo@unict.it (G.R.); valentinadisalvatore@unict.it (V.D.S.); francesco.pappalardo@unict.it (F.P.)
      2. Mimesis Srl, 95125 Catania, Italy
      3. InSilicoTrials Technologies B.V., 5232 AC ‘s-Hertogenbosch, The Netherlands; fianne.sips@insilicotrials.com
      4. InSilicoTrials Technologies Spa, 34123 Trieste, Italy; simona.catozzi@insilicotrials.com (S.C.);pauline.bambury@insilicotrials.com (P.B.); mario.torchia@insilicotrials.com (M.T.); luca.emili@insilicotrials.com (L.E.)
      5. Axoltis Pharma, 69008 Lyon, France; ajanus@axoltis.com (A.J.); ygodfrin@axoltis.com (Y.G.)
      6. * Correspondence: daniel.roeshammar@insilicotrials.com
PDF Version